Press releases

Month Year

Email alerts

May 7, 2015

Medtronic Initiates Study Of ‘In-Office’ Insertion Of Reveal LINQ™ Cardiac Monitor

RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting

DUBLIN – May 7, 2015 – Medtronic plc (NYSE: MDT) today announced the first inoffice implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study....
Feb 19, 2015

Medicare Approves Transitional Pass-Through Payment for Outpatient Use of Medtronic Drug-Coated Balloon

CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Upper Leg

DUBLIN - Feb. 19, 2015 - Medtronic plc (NYSE: MDT) announced today that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company's...
Feb 11, 2015

Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients In ‘Real – World’ Study

Findings Reinforce Patient Benefit of Reveal LINQ in Real-World Setting

DUBLIN and NASHVILLE – Feb. 11, 2015 – Medtronic plc (NYSE: MDT), today announced the results of a new “real-world” study of patients who have had a cryptogenic stroke (stroke of unknown...
Feb 4, 2015

Medtronic Starts U.S. Launch Of IN.PACT Admiral Drug-Coated Balloon For Treatment Of Peripheral arterial Disease In Upper Leg

First Uses of New Medical Device Following FDA Approval Take Place at Hospitals Nationwide

DUBLIN – Feb. 4, 2015 – U.S. hospitals this week began using a new medical device from Medtronic plc (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) to treat patients with...
Jan 29, 2015

Studies Show Benefits of Medtronic SmartShock(TM) Technology and Physician Reports in Protecting Patients from Inappropriate Shocks

New Results from PainFree SST, Shock-Less Studies, Involving Nearly 7,000 Patients, Published in HeartRhythm

DUBLIN and MINNEAPOLIS - Jan. 29, 2015 - Medtronic plc (NYSE: MDT) today announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data...

Show per page